Close Menu

NEW YORK (GenomeWeb) – A collection of new studies suggest that it may be time to rethink cervical cancer screening methods, moving away from cytology-based testing on Pap smear samples and toward direct screening for DNA from human papillomavirus (HPV).

Because the vast majority of cervical cancer cases can be traced back to persistent HPV infection — particularly infections involving HPV16 or HPV18 types — methods have emerged for directly detecting as a means of identifying individuals at risk of the disease who might require enhanced screening.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
26

As new variants of SARS-CoV-2 circulate around the globe, there is growing concern among clinical laboratories that these variants may impact their ability to accurately detect the virus.